ScopusElsevier Scopus
Status
Active
Coverage
2000–2026
Source type
Journal
Open access
No
CiteScore
5.4
Best quartile
Q2 · 66th pctile
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 142 / 428 | 66th | Q2 |
| Cancer Research | 116 / 233 | 50th | Q2 |
Clinical and Translational Oncology
ISSN 1699-048X · 1699-3055
Publisher: Springer Science and Business Media Deutschland GmbH
Scopus · Q2WoS · SCIEONOS
Is Clinical and Translational Oncology indexed in Scopus? Yes — actively indexed in Scopus, coverage 2000–2026, best quartile Q2, CiteScore 5.4.
Is Clinical and Translational Oncology in Web of Science? Yes — indexed in the Science Citation Index Expanded.
Is Clinical and Translational Oncology open access? No — it is not registered as an open-access journal in DOAJ or Scopus.
5.4
CiteScore 2025
Scopus
Q2
Best quartile
66th percentile
2
Indexed in
major indexes
Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)
ABDCAustralian Business Deans Council 2025
Not listed in ABDC.
DOAJDirectory of Open Access Journals (live)
Checking DOAJ…
FT50Financial Times research list
Not listed in FT50.
UT DallasUTD top-100 business research
Not listed in UT Dallas.
ONOS · SubscriptionOne Nation One Subscription — full-text access
This journal is part of the ONOS national subscription — readers at an ONOS-subscribed Indian institution get full-text access to its articles at no cost.
Access depends on your institution’s ONOS participation; the subscribed title list is subject to revision.
Learn about ONOS ONOS · APC coveredOne Nation One Subscription (Govt of India)
Not in the ONOS APC-supported list.
Publishing in this journal is not centrally APC-funded under One Nation One Subscription.
Official sources & links
Related journals
Explore this journal in the interactive dashboard →
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.